Literature DB >> 30499084

A low GLP-1 response among patients treated for acute organophosphate and carbamate poisoning: a comparative cross-sectional study from an agrarian region of Sri Lanka.

Devarajan Rathish1, Indika Senavirathna2, Channa Jayasumana3, Suneth Agampodi4, Sisira Siribaddana5.   

Abstract

Higher incidence of diabetes along with increased use of pesticides is seen in Southeast Asia. Recent hypothesis postulated a link between acetylcholinesterase inhibitor insecticides and type 2 diabetes through the GLP-1 pathway. This study compares the GLP-1 response between groups with low and high red blood cell acetylcholinesterase (RBC-AChE) activity. A comparative cross-sectional study was conducted amongst patients who were within 3 months after an acute organophosphate or carbamate poisoning (acute group) and amongst vegetable farmers with low (chronic group) and high (control group) RBC-AChE activity. Acute (366 mU/μM Hb) and chronic (361 mU/μM Hb) groups had significantly lower RBC-AChE activity in comparison to the control (471 mU/μM Hb) group (P < 0.0001). Only the acute group, which has had atropine therapy, showed a significantly lower 120 min value in comparison to the control group (P = 0.0028). Also, the acute group had significantly low late (P = 0.0287) and total (P = 0.0358) responses of GLP-1 in comparison to the control group. The findings of the study allude towards attenuation of GLP-1 response amongst patients after acute organophosphate and carbamate poisoning. The possibility of an atropine-mediated attenuation of GLP-1 response was discussed.

Entities:  

Keywords:  Acetylcholinesterase activity; Atropine; Carbamate; Diabetes mellitus; Glucagon-like peptide-1; Incretin effect; Organophosphate

Mesh:

Substances:

Year:  2018        PMID: 30499084     DOI: 10.1007/s11356-018-3818-9

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  33 in total

1.  PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.

Authors:  H ELRICK; L STIMMLER; C J HLAD; Y ARAI
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

2.  Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

Authors:  T Vilsbøll; T Krarup; C F Deacon; S Madsbad; J J Holst
Journal:  Diabetes       Date:  2001-03       Impact factor: 9.461

3.  Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice.

Authors:  Bin Li; Ellen G Duysen; Laura A Volpicelli-Daley; Allan I Levey; Oksana Lockridge
Journal:  Pharmacol Biochem Behav       Date:  2003-03       Impact factor: 3.533

4.  Improved determination of acetylcholinesterase activity in human whole blood.

Authors:  F Worek; U Mast; D Kiderlen; C Diepold; P Eyer
Journal:  Clin Chim Acta       Date:  1999-10       Impact factor: 3.786

5.  The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia.

Authors:  B Ahrén; J J Holst
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

6.  Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats.

Authors:  Younes Anini; Tanya Hansotia; Patricia L Brubaker
Journal:  Endocrinology       Date:  2002-06       Impact factor: 4.736

7.  Toxicokinetic and toxicodynamic aspects of organophosphorus (OP) insecticide poisoning.

Authors:  J A Vale
Journal:  Toxicol Lett       Date:  1998-12-28       Impact factor: 4.372

8.  Incident diabetes and pesticide exposure among licensed pesticide applicators: Agricultural Health Study, 1993-2003.

Authors:  M P Montgomery; F Kamel; T M Saldana; M C R Alavanja; D P Sandler
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

Review 9.  The physiology of glucagon-like peptide 1.

Authors:  Jens Juul Holst
Journal:  Physiol Rev       Date:  2007-10       Impact factor: 37.312

Review 10.  Pathophysiology of type 2 diabetes.

Authors:  A J Scheen
Journal:  Acta Clin Belg       Date:  2003 Nov-Dec       Impact factor: 1.264

View more
  3 in total

1.  In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review.

Authors:  Devarajan Rathish; Suneth Agampodi; Channa Jayasumana
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-24       Impact factor: 4.223

2.  Selected Liver Markers in Predicting the Severity of Organophosphate and Carbamate Poisoning.

Authors:  R Senarathne; U Hettiaratchi; L Athiththan; H Peiris; C Sarathchandra; H Senanayake; P Weerawansa; S Siribaddana
Journal:  J Environ Public Health       Date:  2022-06-17

3.  Comparison of biochemical parameters among DPP4 inhibitor users and other oral hypoglycaemic drug users: a cross-sectional study from Anuradhapura, Sri Lanka.

Authors:  Devarajan Rathish; Channa Jayasumana; Suneth Agampodi
Journal:  J Health Popul Nutr       Date:  2019-01-23       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.